Skip to content

Fellow Journal Club

Fellow Journal Club
0
Search
Date
Fellow
Articles
Topic
Subtopic
GYO Lecture
Notes
Links
1
8/5/2021
Newton
SGO Working Group: EMCA Review & Management Parts I &II**
Endometrial
Review
https://www.gyoedu.org/past-lectures/endometrial-cancer-review
https://www.gyoedu.org/past-lectures/early-stage-endometrial-cancer
https://www.gyoedu.org/past-lectures/advanced-stage-and-recurrent-endometrial-cancer
2
8/5/2021
Newton
GOG 99, PORTEC-1,2,3, GOG 249, GOG 258
Endometrial
Radiation/Chemoradiation
https://www.gyoedu.org/past-lectures/endometrial-cancer-review
https://www.gyoedu.org/past-lectures/early-stage-endometrial-cancer
https://www.gyoedu.org/past-lectures/advanced-stage-and-recurrent-endometrial-cancer
3
8/12/2021
Lyn/Lexi
Chemo Teaching
4
8/19/2021
Buckingham
FIRES Trial (2017), Mayo Criteria
Endometrial
Lymph node assessment
https://www.gyoedu.org/past-lectures/sentinel-nodes-in-gynecologic-cancers
https://www.gyoedu.org/past-lectures/management-of-itcs-in-endometrial-cancer
5
8/19/2021
Buckingham
Fader (2018), Keynote 158 (and 2021 SGO abstract), Pembro/lenvatinib Makker (2019)
Endometrial
Targeted therapies
https://www.gyoedu.org/past-lectures/sentinel-nodes-in-gynecologic-cancers
https://www.gyoedu.org/past-lectures/management-of-itcs-in-endometrial-cancer
6
8/26/2021
Burkett
GCIG consensus statement*
LMS
Summary
7
8/26/2021
Burkett
Hensley et al (GOG 87L), GeDDis tria l, Tap et al (Olaratumab), ANNOUNCE trial
LMS
Treatment
8
9/2/2021
O’Donnell
UpToDate article*, Reich (2007), Beck (2011)
ESS
Low grade: Hormonal treatment
9
9/2/2021
O’Donnell
Cantrell (2015)
Carcinosarcoma
Review
10
9/2/2021
O’Donnell
GOG 261 (2019 Abstract)
Carcinosarcoma
Adjuvant CT: Stage I-IV
11
9/9/2021
Lyn/Lexi
Chemo Teaching
12
9/16/2021
John
2 Lurain Reviews (2010), Soper Review (2021)
GTN
Review
https://www.gyoedu.org/past-lectures/gestational-trophoblastic-disease
https://www.gyoedu.org/past-lectures/high-risk-recurrent-gtn
13
9/23/2021
Connor
EOC
Neoadjuvant vs Primary CRS
14
9/30/2021
O’Donnell
Hoskins (Secondary GOG 97 analysis), Chang 2013, du Bois 2009, Fagotti Score (2008)
EOC
Primary Debulking: R0 v R1 v R2; scoring
15
9/30/2021
O’Donnell
LION trial
EOC
Lymphadenectomy?
16
10/7/2021
Newton
GOG 152, EORTC 55865
EOC
Redebulk after suboptimal PCS?
17
10/14/2021
Lyn/Lexi
Chemo Teaching
18
10/21/2021
Burkett
GOG 111, GOG 158, SCOTROC, AOCTG
EOC
Primary adjuvant: History of Carb/Tax
19
10/28/2021
Buckingham
GOG 114, GOG 172, GOG 252*
EOC
Primary adjuvant: IP v IV chemo
20
11/4/2021
John
JGOG 3016, MITO7, GOG 262, ICON8*
EOC
Primary adjuvant: Dose dense Taxol
21
11/11/2021
Lyn/Lexi
Chemo Teaching
22
11/18/2021
Connor
GOG 218, ICON 7
EOC
Primary adjuvant: Is Bev dead?
23
11/25/2021
OFF
THANKSGIVING
24
12/2/2021
Newton
SOLO1, PAOLA-1, PRIMA, VELIA
PARPi for frontline maintenance
https://www.gyoedu.org/past-lectures/parp-inhibitors-in-ovarian-cancer
https://www.gyoedu.org/past-lectures/parp-i-for-non-hrd-population
25
12/9/2021
Lyn/Lexi
Chemo Teaching
26
12/16/2021
Burkett
GOG 213, DESKTOP III*, SOC-1
EOC
Recurrence: Secondary cytoreduction
27
12/23/2021
OFF
CHRISTMAS
28
12/30/2021
OFF
NEW YEAR’S
29
1/13/2022
Lyn & Lexie
Chemo teaching
30
2/10/2022
Lyn & Lexie
Chemo teaching
31
3/3/2022
MN
ICON4/AGO-OVAR2.2, AGO-OVAR 2.5, CALYPSO
EOC
Platinum sensitive recurrence
32
3/10/2022
Lyn & Lexie
Chemo teaching
33
3/17/2022
SGO ANNUAL MEETING – NO FJC THIS WEEK
34
3/24/2022
CJ
AGO/OVAR2.21, OCEANS*, GOG 213*, MITO16b/MANGO-OV2/ENGOT-ov17
Platinum sensitive recurrence + bev
35
3/31/2022
YC
Study 19, SOLO 2*, NOVA, ARIEL 3*, OReO/ENGOT Ov-38 (abstract)
EOC
Maintenance PARP
36
4/7/2022
WB
Study 42, SOLO 3, ARIEL 2*, QUADRA
EOC
Treatment PARP
37
4/14/2022
Lyn & Lexie
Chemo teaching
EOC
38
4/21/2022
CJ
AURELIA*, TOPACIO/Keynote 162, Cochrane review of topotecan (PMID 18425923), Gemcitabine equivocal to doxil (PMID 17602086)
EOC
Platinum resistant recurrence
39
4/28/2022
WB
GOG 241, Morice et al (NEMJ), Kurnit et al (Gyn Onc)
Rare histologies
Mucinous EOC
40
5/5/2022
JO
GOG 45, GOG 78, Gershenson (JCO 2007)**
PARAGON, Simone et al, Homesley et al

Rare histologies
Germ cell, Sex Cord Stromal
41
5/12/2022
Lyn & Lexie
Chemo teaching
42
5/19/2022
YC
Cervix
Surgical treatment
43
5/26/2022
LB
GOG 92, GOG 109, Outback
44
Lanciano et al, Logsdon et al, Cochrane review of HDR vs LDR intracity brachytherapy**
Cervix
Adjuvant treatment
45
Brachytherapy
46
6/2/2022
JO
GOG 123, GOG 120, Cochrane review (PMID 20091664), RTOG 9001**, GOG 85**
Cervix
Primary ChemoRT
47
6/9/2022
MN
GOG 169, GOG 204, GOG 240*
48
JGOG 0505, Keynote 826, innovaTV 204
Cervix
Metastatic/recurrent tx
49
6/16/2022
LB
GOG 141, Gupta et al
50
Cosin et al, Gold et al
51
Bentivegna et al
Cervix
NACT
52
Pre-tx LND
53
Fertility sparing surgery
54
6/30/2022
WB
GOG 191**, Bishop et al**
Cervix
RT and anemia**
There are no rows in this table
Summary in the GYN Oncology Clinical Trials Review Book in the Fellows’ Office
* = The suggested “MUST” reads! **= For reading (don’t have to present)

Want to print your doc?
This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (
CtrlP
) instead.